81 results on '"de Kleine, R"'
Search Results
2. Well-to-wheels emissions, costs, and feedstock potentials for light-duty hydrogen fuel cell vehicles in China in 2017 and 2030
- Author
-
He, X., Wang, F., Wallington, T.J., Shen, W., Melaina, M.W., Kim, H.C., De Kleine, R., Lin, T., Zhang, S., Keoleian, G.A., Lu, X., and Wu, Y.
- Published
- 2021
- Full Text
- View/download PDF
3. Incidence of Isolated Biliary Atresia during the COVID Lockdown in Europe: Results from a Collaborative Project by RARE-Liver
- Author
-
Nomden, M, Alizai, N, Betalli, P, Bruggink, J, Cananzi, M, Christensen, V, D'Antiga, L, Davenport, M, Fischler, B, Hindemith, L, Hukkinen, M, Johansen, L, de Kleine, R, Madadi-Sanjani, O, Ong, E, Pakarinen, M, Petersen, C, Ruiz, M, Schunn, M, Sturm, E, Verkade, H, Wildhaber, B, Hulscher, J, Nomden M., Alizai N. K., Betalli P., Bruggink J. L. M., Cananzi M., Christensen V. B., D'Antiga L., Davenport M., Fischler B., Hindemith L., Hukkinen M., Johansen L. S., de Kleine R. H., Madadi-Sanjani O., Ong E. G. P., Pakarinen M. P., Petersen C., Ruiz M., Schunn M., Sturm E., Verkade H. J., Wildhaber B. E., Hulscher J. B. F., Nomden, M, Alizai, N, Betalli, P, Bruggink, J, Cananzi, M, Christensen, V, D'Antiga, L, Davenport, M, Fischler, B, Hindemith, L, Hukkinen, M, Johansen, L, de Kleine, R, Madadi-Sanjani, O, Ong, E, Pakarinen, M, Petersen, C, Ruiz, M, Schunn, M, Sturm, E, Verkade, H, Wildhaber, B, Hulscher, J, Nomden M., Alizai N. K., Betalli P., Bruggink J. L. M., Cananzi M., Christensen V. B., D'Antiga L., Davenport M., Fischler B., Hindemith L., Hukkinen M., Johansen L. S., de Kleine R. H., Madadi-Sanjani O., Ong E. G. P., Pakarinen M. P., Petersen C., Ruiz M., Schunn M., Sturm E., Verkade H. J., Wildhaber B. E., and Hulscher J. B. F.
- Abstract
Background: Biliary atresia (BA) is a rare cholangiopathy where one of the proposed aetiological mechanisms is an infectious viral trigger. Coronavirus disease-19 (COVID) lockdown restrictions were implemented to reduce the transmission of infections. Strictness of lockdown varied across European countries. This study aimed to investigate if there was an association between strictness of lockdown and change in isolated BA (IBA) incidence in Europe. Methods: We approached European centres involved in the European Reference Network RARE-LIVER. We included IBA patients born between 2015 and June 2020. We calculated the number of IBA patients born per centre per month. The Stringency Index (SI) was used as lockdown strictness indicator. The association between percentage change of mean number of IBA patients born per month and the SI was assessed. Results: We included 412 IBA patients from thirteen different centres. The median number of patients per month did not change: 6 (1–15) pre-lockdown and 7 (6–9) during lockdown (p = 0.34). There was an inverse association between SI and percentage change in IBA (B = -0.73, p = 0.03). Median age at Kasai portoenterostomy (days) did not differ between time periods (51 (9–179) vs. 53 (19–126), p = 0.73). Conclusion: In this European study, a stricter COVID-lockdown was seemingly accompanied by a simultaneous larger decrease in the number of IBA patients born per month in the lockdown. Results should be interpreted with caution due to the assumptions and limitations of the analysis.
- Published
- 2023
4. Severe acute hepatitis and acute liver failure of unknown origin in children: a questionnaire-based study within 34 paediatric liver centres in 22 European countries and Israel, April 2022
- Author
-
de Kleine, R, Lexmond, W, Buescher, G, Sturm, E, Kelly, D, Lohse, A, Lenz, D, Jorgensen, M, Protopapa, P, Shteyer, E, Iorio, R, Pukite, I, Kucinskiene, R, Grima, A, Koot, B, Pop, T, De Bruyne, R, Stephenne, Vukovic, J, Mitrova, K, Kvistgaard, H, Merras-Salmio, L, Hery, G, Debray, D, Ruiz, M, Schulz-Jurgensen, S, Lurz, E, Hives, V, Cananzi, M, D'Antiga, L, di Giorgio, A, Pinon, M, Kaminska, D, Costa, I, Brecelj, J, Bartolo, G, Quintero, J, Fischler, B, Mclin, V, de Kleine R. H., Lexmond W. S., Buescher G., Sturm E., Kelly D., Lohse A. W., Lenz D., Jorgensen M. H., Protopapa P., Shteyer E., Iorio R., Pukite I., Kucinskiene R., Grima A. -M., Koot B., Pop T. L., De Bruyne R., Vukovic J., Mitrova K., Kvistgaard H., Merras-Salmio L., Hery G., Debray D., Ruiz M., Schulz-Jurgensen S., Lurz E., Hives V., Cananzi M., D'Antiga L., di Giorgio A., Pinon M., Kaminska D., Costa I. G., Brecelj J., Bartolo G. M., Quintero J., Fischler B., McLin V., de Kleine, R, Lexmond, W, Buescher, G, Sturm, E, Kelly, D, Lohse, A, Lenz, D, Jorgensen, M, Protopapa, P, Shteyer, E, Iorio, R, Pukite, I, Kucinskiene, R, Grima, A, Koot, B, Pop, T, De Bruyne, R, Stephenne, Vukovic, J, Mitrova, K, Kvistgaard, H, Merras-Salmio, L, Hery, G, Debray, D, Ruiz, M, Schulz-Jurgensen, S, Lurz, E, Hives, V, Cananzi, M, D'Antiga, L, di Giorgio, A, Pinon, M, Kaminska, D, Costa, I, Brecelj, J, Bartolo, G, Quintero, J, Fischler, B, Mclin, V, de Kleine R. H., Lexmond W. S., Buescher G., Sturm E., Kelly D., Lohse A. W., Lenz D., Jorgensen M. H., Protopapa P., Shteyer E., Iorio R., Pukite I., Kucinskiene R., Grima A. -M., Koot B., Pop T. L., De Bruyne R., Vukovic J., Mitrova K., Kvistgaard H., Merras-Salmio L., Hery G., Debray D., Ruiz M., Schulz-Jurgensen S., Lurz E., Hives V., Cananzi M., D'Antiga L., di Giorgio A., Pinon M., Kaminska D., Costa I. G., Brecelj J., Bartolo G. M., Quintero J., Fischler B., and McLin V.
- Abstract
To detect potential concern about severe acute hepatitis in children, we conducted a survey among 50 ERN RARE-LIVER centres. By 26 April 2022, 34 centres, including 25 transplant centres, reported an estimated median of 3-5, 0-2 and 3-5 cases in 2021, 2020 and 2019 and a mean of 2 (range: 0-8) cases between January and April 2022 (mean in 10 large liver transplant centres: 3). Twelve centres reported suspicion of an increase, but no rise. Following a report by the United Kingdom (UK) on 5 April 2022 on the occurrence of cases of severe acute hepatitis in children aged 16 years or under, the World Health Organization (WHO) raised concerns about the possibility of an epidemic [1,2]. By 21 April, 169 possible or confirmed cases were reported fulfilling the WHO case definition [3]. The cause of the hepatitis is unknown but a link to a virus infection has been suggested due to the epidemiological pattern of cases [4,5]. The hepatitis can progress to paediatric acute liver failure (pALF) necessitating urgent liver transplantation to avoid multi-organ failure [6]. We intended to assess whether a rise in incidence of severe acute hepatitis or pALF could be observed between 1 January and 26 April 2022 in comparison to previous years, within the European Reference Network on Hepatological Diseases (ERN RARE-LIVER) [7].
- Published
- 2022
5. Improving treatment for patients with childhood abuse related posttraumatic stress disorder (IMPACT study): protocol for a multicenter randomized trial comparing prolonged exposure with intensified prolonged exposure and phase-based treatment
- Author
-
Oprel, D. A. C., Hoeboer, C. M., Schoorl, M., De Kleine, R. A., Wigard, I. G., Cloitre, M., Van Minnen, A., and Van der Does, W.
- Published
- 2018
- Full Text
- View/download PDF
6. European Liver Transplant Registry: Donor and transplant surgery aspects of 16,641 liver transplantations in children
- Author
-
de Ville de Goyet, J, Baumann, U, Karam, V, Adam, R, Nadalin, S, Heaton, N, Reding, R, Branchereau, S, Mirza, D, Klempnauer, J, Fischer, L, Kalicinski, P, Colledan, M, Lopez Santamaria, M, de Kleine, R, Chardot, C, Yilmaz, S, Kilic, M, Boillot, O, di Francesco, F, Polak, W, Verkade, H, de Ville de Goyet, Jean, Baumann, Ulrich, Karam, Vincent, Adam, René, Nadalin, Silvio, Heaton, Nigel, Reding, Raymond, Branchereau, Sophie, Mirza, Darius, Klempnauer, Jürgen L, Fischer, Lutz, Kalicinski, Piotr, Colledan, Michele, Lopez Santamaria, Manuel, de Kleine, Ruben H, Chardot, Christophe, Yilmaz, Sezai, Kilic, Murat, Boillot, Olivier, di Francesco, Fabrizio, Polak, Wojciech G, Verkade, Henkjan J, de Ville de Goyet, J, Baumann, U, Karam, V, Adam, R, Nadalin, S, Heaton, N, Reding, R, Branchereau, S, Mirza, D, Klempnauer, J, Fischer, L, Kalicinski, P, Colledan, M, Lopez Santamaria, M, de Kleine, R, Chardot, C, Yilmaz, S, Kilic, M, Boillot, O, di Francesco, F, Polak, W, Verkade, H, de Ville de Goyet, Jean, Baumann, Ulrich, Karam, Vincent, Adam, René, Nadalin, Silvio, Heaton, Nigel, Reding, Raymond, Branchereau, Sophie, Mirza, Darius, Klempnauer, Jürgen L, Fischer, Lutz, Kalicinski, Piotr, Colledan, Michele, Lopez Santamaria, Manuel, de Kleine, Ruben H, Chardot, Christophe, Yilmaz, Sezai, Kilic, Murat, Boillot, Olivier, di Francesco, Fabrizio, Polak, Wojciech G, and Verkade, Henkjan J
- Abstract
Background and Aims: The European Liver Transplant Registry (ELTR) has collected data on liver transplant procedures performed in Europe since 1968. Approach and Results: Over a 50-year period (1968–2017), clinical and laboratory data were collected from 133 transplant centers and analyzed retrospectively (16,641 liver transplants in 14,515 children). Data were analyzed according to three successive periods (A, before 2000; B, 2000–2009; and C, since 2010), studying donor and graft characteristics and graft outcome. The use of living donors steadily increased from A to C (A, n = 296 [7%]; B, n = 1131 [23%]; and C, n = 1985 [39%]; p = 0.0001). Overall, the 5-year graft survival rate has improved from 65% in group A to 75% in group B (p < 0.0001) and to 79% in group C (B versus C, p < 0.0001). Graft half-life was 31 years, overall; it was 41 years for children who survived the first year after transplant. The late annual graft loss rate in teenagers is higher than that in children aged <12 years and similar to that of young adults. No evidence for accelerated graft loss after age 18 years was found. Conclusions: Pediatric liver transplantation has reached a high efficacy as a cure or treatment for severe liver disease in infants and children. Grafts that survived the first year had a half-life similar to standard human half-life. Transplantation before or after puberty may be the pivot-point for lower long-term outcome in children. Further studies are necessary to revisit some old concepts regarding transplant benefit (survival time) for small children, the role of recipient pathophysiology versus graft aging, and risk at transition to adult age.
- Published
- 2022
7. Surgery for multiple endocrine neoplasia type 1-related insulinoma
- Author
-
van Beek, D. J., Nell, S., Verkooijen, H. M., Borel Rinkes, I. H. M., Valk, G. D., Vriens, M. R., Goudet, P., Vella, A., Donegan, D., Bartsch, D. K., Manoharan, J., Perrier, N. D., Christakis, I., Brandi, M. L., Zarnegar, R., Postma, E. L., Kebebew, E., Nockel, P., Brunaud, L., Pasternak, J. D., Kluijfhout, W. P., Sturgeon, C., Giri, S., Bonsing, B. A., van Eijck, C. H., van Goor, H., de Kleine, R. H. J., van Dijkum, E. J. Nieveen, Dejong, C. H. C., Surgery, Amsterdam Gastroenterology Endocrinology Metabolism, Clinical Genetics, and Department of Finance
- Subjects
Male ,endocrine system diseases ,Kaplan-Meier Estimate ,0302 clinical medicine ,Postoperative Complications ,Multiple endocrine neoplasia ,Child ,Aged, 80 and over ,Middle Aged ,medicine.anatomical_structure ,Treatment Outcome ,030220 oncology & carcinogenesis ,HPB ,Child, Preschool ,Original Article ,Female ,Pancreas ,hormones, hormone substitutes, and hormone antagonists ,Adult ,medicine.medical_specialty ,endocrine system ,Adolescent ,Enucleation ,Clinical Decision-Making ,030209 endocrinology & metabolism ,Hypoglycemia ,03 medical and health sciences ,Young Adult ,Pancreatectomy ,medicine ,Multiple Endocrine Neoplasia Type 1 ,Humans ,MEN1 ,General ,Survival rate ,Insulinoma ,Aged ,Retrospective Studies ,business.industry ,Original Articles ,medicine.disease ,Surgery ,Reconstructive and regenerative medicine Radboud Institute for Health Sciences [Radboudumc 10] ,Pancreatic Neoplasms ,Localized disease ,Neoplasm Recurrence, Local ,business ,Follow-Up Studies - Abstract
Background Insulinomas are found in 10–15 per cent of patients with multiple endocrine neoplasia type 1 (MEN1) and lead to life‐threatening hypoglycaemia. Surgical outcome and the optimal surgical strategy for MEN1‐related insulinoma are unknown. Methods Patients with MEN1‐related insulinomas were identified in 46 centres in Europe and North America between 1990 and 2016. Insulinomas were considered localized if the lesion was in the pancreatic head or body/tail. Patients with pancreatic neuroendocrine tumours throughout the pancreas were suspected of having multifocal insulinoma. The primary outcome was postoperative hypoglycaemia, defined as persistent hypoglycaemia, or recurrent hypoglycaemia caused by a new insulinoma or insulin‐producing liver metastases. Hypoglycaemia‐free survival was estimated by the Kaplan–Meier method. Results Ninety‐six patients underwent resection for MEN1‐related insulinoma. Sixty‐three and 33 patients had localized and multifocal insulinomas respectively. After a median follow‐up of 8 (range 1–22) years, one patient (1 per cent) had persistent disease and six (6 per cent) had developed recurrent disease, of whom four had a new insulinoma. The 10‐year hypoglycaemia‐free survival rate was 91 (95 per cent c.i. 80 to 96) per cent. Of those with localized disease, 46 patients underwent pancreatic resection and 17 enucleation. One of these patients had persistent disease and one developed recurrent insulinoma. Among patients with multifocal disease, three developed new insulinomas and two developed insulin‐producing liver metastases. Conclusion Surgery for MEN1‐related insulinoma is more successful than previously thought., In this cohort of 96 patients with resected multiple endocrine neoplasia 1 (MEN1)‐related insulinomas, seven patients (7 per cent) developed postoperative persistent or recurrent hypoglycaemia after a median follow‐up of 8 years. The 10‐year hypoglycaemia‐free survival rate was 91 (95 per cent c.i. 80 to 96) per cent. For patients with localized insulinoma, enucleation seems the preferred procedure. PPPD, pylorus‐preserving pancreatoduodenectomy. Outcomes good
- Published
- 2020
8. Een 16-jarig meisje met klappende armen en benen
- Author
-
de kleine, r. a. and Hoogduin, Kees
- Published
- 2010
- Full Text
- View/download PDF
9. Life cycle environmental assessment of a transition to mobility servitization
- Author
-
Fernando, C, Soo, VK, Compston, P, Kim, HC, de Kleine, R, Weigl, D, Keith, DR, Doolan, M, Fernando, C, Soo, VK, Compston, P, Kim, HC, de Kleine, R, Weigl, D, Keith, DR, and Doolan, M
- Abstract
Mobility servitization modes are increasingly popular and some literature has suggested that their environmental impacts are less than those of privately owned cars. This research assesses the greenhouse gas (GHG) emissions of mobility servitization based on different scenarios: carsharing, carpooling and car ownership (representing the range of occupancy rates), and the changes in vehicle technology (lightweighting and electrification). Life Cycle Assessment is selected as the method and results are interpreted in passenger kilometre. The highest GHG reduction is recorded in pooled adoption scenario, representing the highest occupancy rate in servitization modes. The increasing trends of vehicle lightweighting and electrification can potentially reduce the GHG impacts (during production and use phases) by 35-37%.
- Published
- 2020
10. Choledochal malformations in adults in the Netherlands: Results from a nationwide retrospective cohort study
- Author
-
de Kleine, R H J, Schreuder, AM, ten Hove, A, Hulscher, JBF, Rinkes, IHMB, Dejong, CHC, de Jonge, Jeroen, de Reuver, P, Erdmann, J, Kazemier, G, Gulik, TM, Gouw, ASH, Porte, RJ, de Kleine, R H J, Schreuder, AM, ten Hove, A, Hulscher, JBF, Rinkes, IHMB, Dejong, CHC, de Jonge, Jeroen, de Reuver, P, Erdmann, J, Kazemier, G, Gulik, TM, Gouw, ASH, and Porte, RJ
- Published
- 2020
11. Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease
- Author
-
Verstegen, Monique, Roos, Floris, Burka, Kseniia, Gehart, H, Jager, M, de Wolf, M (Maaike), Bijvelds, Marcel, de Jonge, Hugo, Ardisasmita, AI, van Huizen, Nick, Roest, Henk, de Jonge, Jeroen, Koch, M, Pampaloni, F, Fuchs, SA, Schene, IF, Luider, Theo, van der Doef, HPJ, Bodewes, FAJA, de Kleine, R H J, Spee, B, Kremers, Gert-Jan, Clevers, H, IJzermans, J.N.M., Cuppen, E, van der Laan, Luc, Verstegen, Monique, Roos, Floris, Burka, Kseniia, Gehart, H, Jager, M, de Wolf, M (Maaike), Bijvelds, Marcel, de Jonge, Hugo, Ardisasmita, AI, van Huizen, Nick, Roest, Henk, de Jonge, Jeroen, Koch, M, Pampaloni, F, Fuchs, SA, Schene, IF, Luider, Theo, van der Doef, HPJ, Bodewes, FAJA, de Kleine, R H J, Spee, B, Kremers, Gert-Jan, Clevers, H, IJzermans, J.N.M., Cuppen, E, and van der Laan, Luc
- Published
- 2020
12. Impact of dissociation on the effectiveness of psychotherapy for post-traumatic stress disorder: meta-analysis
- Author
-
Hoeboer, C. M., primary, De Kleine, R. A., additional, Molendijk, M. L., additional, Schoorl, M., additional, Oprel, D. A. C., additional, Mouthaan, J., additional, Van der Does, W., additional, and Van Minnen, A., additional
- Published
- 2020
- Full Text
- View/download PDF
13. Choledochal malformations in adult patients: Results from a national registry in a Western population
- Author
-
Schreuder, A.M., primary, De Kleine, R., additional, Hove, A Ten, additional, Hulscher, J., additional, Van Gulik, T., additional, Gouw, A., additional, and Porte, R., additional
- Published
- 2020
- Full Text
- View/download PDF
14. Management of portal vein anastomotic stenosis after pediatric liver transplantation: Evaluation of single center experience
- Author
-
De Kleine, R., primary, Bokkers, R., additional, Porte, R., additional, Dikkers, R., additional, De Haas, R.J., additional, Kater, M., additional, Bodewes, F., additional, and Van de Doef, H., additional
- Published
- 2020
- Full Text
- View/download PDF
15. Biliary bicarbonate, pH and glucose are suitable biomarkers of biliary viability during ex situ normothermic machine perfusion of human donor livers
- Author
-
Matton, A. P. M., de Vries, Y., van Leeuwen, O. B., Burlage, L. C., van Rijn, R., Fujiyoshi, M., de Meijer, V. E., Ubbink, R., Pelgrim, G. J., Werner, M. J. M., Reyntjens, K., van den Berg, A. P., de Boer, M. T., de Kleine, R. H. J., Verkade, H. J., Gouw, A. S. H., Lisman, T., Porte, R. J., Groningen Institute for Organ Transplantation (GIOT), Center for Liver, Digestive and Metabolic Diseases (CLDM), and Lifestyle Medicine (LM)
- Published
- 2019
16. Long-term neurodevelopmental outcomes in children with biliary atresia
- Author
-
Rodijk, L. H., den Heijer, A. E., Hulscher, J. B. F., Verkade, H. J., de Kleine, R. H. J., Bruggink, J. L. M., Clinical Neuropsychology, Center for Liver, Digestive and Metabolic Diseases (CLDM), and Lifestyle Medicine (LM)
- Published
- 2019
17. Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial)
- Author
-
van Hilst, J., Strating, E. A., de Rooij, T., Daams, F., Festen, S., Groot Koerkamp, B., Klaase, J. M., Luyer, M., Dijkgraaf, M. G., Besselink, M. G., van Santvoort, H. C., de Boer, M. T., Boerma, D., van den Boezem, P. B., van Dam, R. M., Dejong, C. H., van Duyn, E. B., van Eijck, C. H., Gerhards, M. F., de Hingh, I. H., Kazemier, G., de Kleine, R. H., van Laarhoven, C. J., Patijn, G. A., Steenvoorde, P., Suker, M., Hilal, M. Abu, RS: NUTRIM - R2 - Liver and digestive health, MUMC+: MA Heelkunde (9), Surgery, Groningen Institute for Organ Transplantation (GIOT), Value, Affordability and Sustainability (VALUE), AGEM - Re-generation and cancer of the digestive system, CCA - Cancer Treatment and quality of life, Epidemiology and Data Science, APH - Methodology, AGEM - Digestive immunity, and CCA - Cancer Treatment and Quality of Life
- Subjects
Male ,Cost effectiveness ,SURGERY ,Cost-Benefit Analysis ,INTERNATIONAL STUDY-GROUP ,OPEN ILEOCOLIC RESECTION ,law.invention ,BODY-IMAGE ,Tumours of the digestive tract Radboud Institute for Health Sciences [Radboudumc 14] ,Postoperative Complications ,0302 clinical medicine ,Robotic Surgical Procedures ,Quality of life ,Randomized controlled trial ,law ,Hospital Costs/statistics & numerical data ,Outcome Assessment, Health Care ,80 and over ,Single-Blind Method ,Hospital Costs ,Laparoscopy ,Netherlands ,Aged, 80 and over ,medicine.diagnostic_test ,Middle Aged ,Multicenter Study ,Patient Satisfaction ,030220 oncology & carcinogenesis ,Randomized Controlled Trial ,Original Article ,030211 gastroenterology & hepatology ,Female ,Quality-Adjusted Life Years ,Adult ,medicine.medical_specialty ,Pancreatectomy/economics ,COSMESIS ,03 medical and health sciences ,Outcome Assessment (Health Care) ,All institutes and research themes of the Radboud University Medical Center ,Pancreatectomy ,Patient satisfaction ,medicine ,Journal Article ,Humans ,Comparative Study ,Aged ,Laparoscopy/economics ,business.industry ,Cosmesis ,Original Articles ,Recovery of Function ,Confidence interval ,Surgery ,Quality-adjusted life year ,Postoperative Complications/economics ,DEFINITION ,Quality of Life ,Robotic Surgical Procedures/economics ,business ,Follow-Up Studies - Abstract
Background Minimally invasive distal pancreatectomy decreases time to functional recovery compared with open distal pancreatectomy, but the cost-effectiveness and impact on disease-specific quality of life have yet to be established. Methods The LEOPARD trial randomized patients to minimally invasive (robot-assisted or laparoscopic) or open distal pancreatectomy in 14 Dutch centres between April 2015 and March 2017. Use of hospital healthcare resources, complications and disease-specific quality of life were recorded up to 1 year after surgery. Unit costs of hospital healthcare resources were determined, and cost-effectiveness and cost–utility analyses were performed. Primary outcomes were the costs per day earlier functional recovery and per quality-adjusted life-year. Results All 104 patients who had a distal pancreatectomy (48 minimally invasive and 56 open) in the trial were included in this study. Patients who underwent a robot-assisted procedure were excluded from the cost analysis. Total medical costs were comparable after laparoscopic and open distal pancreatectomy (mean difference €–427 (95 per cent bias-corrected and accelerated confidence interval €–4700 to 3613; P = 0·839). Laparoscopic distal pancreatectomy was shown to have a probability of at least 0·566 of being more cost-effective than the open approach at a willingness-to-pay threshold of €0 per day of earlier recovery, and a probability of 0·676 per additional quality-adjusted life-year at a willingness-to-pay threshold of €80 000. There were no significant differences in cosmetic satisfaction scores (median 9 (i.q.r. 5·75–10) versus 7 (4–8·75); P = 0·056) and disease-specific quality of life after minimally invasive (laparoscopic and robot-assisted procedures) versus open distal pancreatectomy. Conclusion Laparoscopic distal pancreatectomy was at least as cost-effective as open distal pancreatectomy in terms of time to functional recovery and quality-adjusted life-years. Cosmesis and quality of life were similar in the two groups 1 year after surgery.
- Published
- 2019
18. Costs and quality of life in a randomized trial comparing minimally invasive and open distal pancreatectomy (LEOPARD trial)
- Author
-
van Hilst, J, Strating, EA, Rooij, T, Daams, F, Festen, S, Groot Koerkamp, B, Klaase, JM, Luyer, M, Dijkgraaf, MG, Besselink, MG, van Santvoort, HC, de Boer, MT, Boerma, D, van den Boezem, PB, van Dam, RM, DeJong, CH, van Duyn, EB, van Eijck, Casper, Gerhards, MF, de Hingh, IH, Kazemier, G, de Kleine, R H, van Laarhoven, CJ, Patijn, GA, Steenvoorde, P, Suker, M, Abu Hilal, M, van Hilst, J, Strating, EA, Rooij, T, Daams, F, Festen, S, Groot Koerkamp, B, Klaase, JM, Luyer, M, Dijkgraaf, MG, Besselink, MG, van Santvoort, HC, de Boer, MT, Boerma, D, van den Boezem, PB, van Dam, RM, DeJong, CH, van Duyn, EB, van Eijck, Casper, Gerhards, MF, de Hingh, IH, Kazemier, G, de Kleine, R H, van Laarhoven, CJ, Patijn, GA, Steenvoorde, P, Suker, M, and Abu Hilal, M
- Published
- 2019
19. Gut Microbiota Composition of Biliary Atresia Patients Before Kasai Portoenterostomy Associates With Long-term Outcome.
- Author
-
van Wessel, Daan, Nomden, Mark, Bruggink, Janneke, de Kleine, Ruben, Kurilshikov, Alexander, Verkade, Henkjan, Harmsen, Hermie, Hulscher, Jan, van Wessel, Daan B E, Nomden, M, Bruggink, J L M, de Kleine, R H J, Kurilshikov, A, Verkade, H J, Harmsen, H J M, and Hulscher, Jan B F
- Published
- 2021
- Full Text
- View/download PDF
20. Levertransplantaties bij kinderen in Nederland
- Author
-
Werner, M J M, de Kleine, R H J, Bodewes, F A J A, de Boer, M T, de Jong, K P, de Meijer, V E, Scheenstra, R, Sieders, E, Verkade, H J J, Porte, R J, Groningen Institute for Organ Transplantation, Guided Treatment in Optimal Selected Cancer Patients, Center for Liver, Digestive and Metabolic Diseases, and Lifestyle Medicine
- Subjects
Journal Article ,English Abstract - Abstract
OBJECTIVE: To evaluate the results of the national paediatric liver transplantation programme in the University Medical Centre (UMC) Groningen in the Netherlands during the past two decades. DESIGN: Retrospective cohort study. METHOD: We analysed data from paediatric patients who underwent liver transplantation at UMC Groningen in the period 1995-2016. We compared outcomes from children who had undergone a liver transplantation in the period 1995-2005 (cohort A; n = 126) and in the period 2006-2016 (cohort B; n = 169). We performed a subanalysis in cohort B between liver transplantations with deceased donor livers (n = 132) and living donor liver transplantations (LDLT; n = 37). RESULTS: In cohort A, almost all livers came from deceased donors (99%), whereas in cohort B, 37 LDLTs (22%) were performed. The median age of recipients was significantly higher in cohort A (4.4 vs. 2.5 years; p = 0.015). Postoperative complications were comparable for both cohorts. Re-transplantations within a year after transplantation were more often performed in cohort A than in cohort B (25% vs. 12%; p = 0.004). Following LDLT, there was 2 times (5.4%) an indication for re-transplantation. In cohort B the 5-year survival rate was better than in cohort A (83 vs. 71%; p = 0.014). In cohort B, 5-year survival was higher after LDLT than after transplantation with a deceased donor liver (95 vs. 81%; p = 0.025). CONCLUSION: Outcomes after paediatric liver transplantation in the Netherlands have further improved during the past two decades. With an actuarial 5-year survival of 83% in the most recent cohort, and as high as 95% following LDLT, we can say that the UMC Groningen has a successful national paediatric liver transplant programme.
- Published
- 2017
21. Meta-analysis of risk of developing malignancy in congenital choledochal malformation
- Author
-
ten Hove, A, primary, de Meijer, V E, additional, Hulscher, J B F, additional, and de Kleine, R H J, additional
- Published
- 2018
- Full Text
- View/download PDF
22. Choledochal Malformation in Children: Lessons Learned from a Dutch National Study
- Author
-
van den Eijnden, MHA, de Kleine, R H J, de Blaauw, I, Peeters, P, Koot, BPG, Oomen, MWN, Sloots, C.E.J., van Gemert, WG, van der Zee, DC, van Heurn, LWE, Verkade, HJ, Wilde, JCH, Hulscher, JBF, van den Eijnden, MHA, de Kleine, R H J, de Blaauw, I, Peeters, P, Koot, BPG, Oomen, MWN, Sloots, C.E.J., van Gemert, WG, van der Zee, DC, van Heurn, LWE, Verkade, HJ, Wilde, JCH, and Hulscher, JBF
- Published
- 2017
23. Minimally invasive versus open distal pancreatectomy (LEOPARD): study protocol for a randomized controlled trial
- Author
-
de Rooij, T, van Hilst, J, Vogel, J A, van Santvoort, HC, de Boer, MT, Boerma, D, van den Boezem, PB, Bonsing, BA, Bosscha, K, Coene, PP, Daams, F, van Dam, RM, Dijkgraaf, MG, van Eijck, Casper, Festen, S, Gerhards, MF, Groot Koerkamp, B, Hagendoorn, J, van der Harst, E, de Hingh, IH, DeJong, CH, Kazemier, G, Klaase, J, de Kleine, R H, van Laarhoven, CJ, Lips, DJ, Luyer, MD, Molenaar, IQ, Nieuwenhuijs, VB, Patijn, GA, Roos, D, Scheepers, JJ, van der Schelling, GP, Steenvoorde, P, Swijnenburg, RJ, Wijsman, JH, Abu Hilal, M, Busch, OR, Besselink, MG, de Rooij, T, van Hilst, J, Vogel, J A, van Santvoort, HC, de Boer, MT, Boerma, D, van den Boezem, PB, Bonsing, BA, Bosscha, K, Coene, PP, Daams, F, van Dam, RM, Dijkgraaf, MG, van Eijck, Casper, Festen, S, Gerhards, MF, Groot Koerkamp, B, Hagendoorn, J, van der Harst, E, de Hingh, IH, DeJong, CH, Kazemier, G, Klaase, J, de Kleine, R H, van Laarhoven, CJ, Lips, DJ, Luyer, MD, Molenaar, IQ, Nieuwenhuijs, VB, Patijn, GA, Roos, D, Scheepers, JJ, van der Schelling, GP, Steenvoorde, P, Swijnenburg, RJ, Wijsman, JH, Abu Hilal, M, Busch, OR, and Besselink, MG
- Published
- 2017
24. Dual hypothermic oxygenated machine perfusion in liver transplants donated after circulatory death
- Author
-
van Rijn, R, primary, Karimian, N, additional, Matton, A P M, additional, Burlage, L C, additional, Westerkamp, A C, additional, van den Berg, A P, additional, de Kleine, R H J, additional, de Boer, M T, additional, Lisman, T, additional, and Porte, R J, additional
- Published
- 2017
- Full Text
- View/download PDF
25. Choledochal malformation in the netherlands: A survey from the netherlands study group on choledochal cystsmalformation registry (NeSCHoC)
- Author
-
De Kleine, R., primary, Van Den Eijnden, M., additional, Wilde, J., additional, Sloots, C., additional, Oomen, M., additional, Van Heurn, E., additional, De Blaauw, I., additional, Van Der Zee, D., additional, Verkade, H.-J., additional, Peeters, P., additional, and Hulscher, J., additional
- Published
- 2016
- Full Text
- View/download PDF
26. The fate of antenatally detected choledochal cysts: a review of a national registry
- Author
-
De Kleine, R., primary, Van den Eijnden, M., additional, Wilde, J., additional, Oomen, M., additional, Sloots, C., additional, Van Heurn, E., additional, De Blaauw, I., additional, Van Der Zee, D., additional, Verkade, H.-J., additional, Peeters, P., additional, and Hulscher, J., additional
- Published
- 2016
- Full Text
- View/download PDF
27. Oxygenated hypothermic machine perfusion in liver transplantation with donation after circulatory death grafts: First clinical series
- Author
-
van Rijn, R., primary, Karimian, N., additional, Matton, A., additional, Burlage, L.C., additional, Westerkamp, A.C., additional, Wiersema-Buist, J., additional, de Kleine, R., additional, de Boer, M.T., additional, van den Berg, A.P., additional, and Porte, R.J., additional
- Published
- 2016
- Full Text
- View/download PDF
28. European Liver Transplant Registry: Donor and transplant surgery aspects of 16,641 liver transplantations in children
- Author
-
de Ville de Goyet, Jean, Baumann, Ulrich, Karam, Vincent, Adam, René, Nadalin, Silvio, Heaton, Nigel, Reding, Raymond, Branchereau, Sophie, Mirza, Darius, Klempnauer, Jürgen L, Fischer, Lutz, Kalicinski, Piotr, Colledan, Michele, Lopez Santamaria, Manuel, de Kleine, Ruben H, Chardot, Christophe, Yilmaz, Sezai, Kilic, Murat, Boillot, Olivier, di Francesco, Fabrizio, Polak, Wojciech G, Verkade, Henkjan J, European Liver, Intestine Transplant Association (ELITA), de Ville de Goyet, J, Baumann, U, Karam, V, Adam, R, Nadalin, S, Heaton, N, Reding, R, Branchereau, S, Mirza, D, Klempnauer, J, Fischer, L, Kalicinski, P, Colledan, M, Lopez Santamaria, M, de Kleine, R, Chardot, C, Yilmaz, S, Kilic, M, Boillot, O, di Francesco, F, Polak, W, Verkade, H, UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation, UCL - (SLuc) Service de chirurgie et transplantation abdominale, and Center for Liver, Digestive and Metabolic Diseases (CLDM)
- Subjects
Graft Rejection ,Male ,Registrie ,medicine.medical_specialty ,Innovative technique ,Survival rate ,Tissue and Organ Procurement ,Adolescent ,Innovative techniques ,medicine.medical_treatment ,Liver transplantation ,Pediatric liver transplantation ,Group B ,Time ,Liver disease ,Transplant surgery ,Transplantation Immunology ,medicine ,Living Donors ,Humans ,Registries ,Child ,COMPLICATIONS ,Hepatology ,business.industry ,Age Factors ,Infant ,Graft survival ,medicine.disease ,Pathophysiology ,Surgery ,Liver Transplantation ,Transplantation ,Europe ,RECIPIENTS ,surgical procedures, operative ,SURVIVAL ,Female ,business - Abstract
BACKGROUND & AIMS: The European Liver Transplant Registry (ELTR) has collected data on liver transplant procedures performed in Europe since 1968.APPROACH & RESULTS: Over a 50 years period (1968 - 2017), clinical and laboratory data were collected from 133 transplant centers and analyzed retrospectively (16,641 liver transplants in 14,515 children). Data were analyzed according to 3 successive periods (A: before 2000, B: 2000 to 2009, and C: since 2010), studying donor and graft characteristics, and graft outcome. The use of living donors steadily increased from A to C [A: n=296 (7%), B: n=1131 (23%) and C: n=1985 (39%); P=0.0001]. Overall, the 5-year graft survival rate has improved from 65% in group A to 75% in group B (pCONCLUSIONS: Pediatric liver transplantation has reached a high efficacy as a cure, or treatment, for severe liver disease in infants and children. Grafts that survived the first year had a half-life time similar to standard human half-life. Transplantation before or after puberty may be the pivot-point for lower long-term outcome in children. Further studies are necessary to re-visit some old concepts regarding transplant benefit (survival time) for small children, the role of recipient pathophysiology versus graft aging, and risk at transition to adult age.
- Published
- 2022
29. Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial
- Author
-
Jony van Hilst, Maarten Korrel, Sanne Lof, Thijs de Rooij, Frederique Vissers, Bilal Al-Sarireh, Adnan Alseidi, Adrian C. Bateman, Bergthor Björnsson, Ugo Boggi, Svein Olav Bratlie, Olivier Busch, Giovanni Butturini, Riccardo Casadei, Frederike Dijk, Safi Dokmak, Bjorn Edwin, Casper van Eijck, Alessandro Esposito, Jean-Michel Fabre, Massimo Falconi, Giovanni Ferrari, David Fuks, Bas Groot Koerkamp, Thilo Hackert, Tobias Keck, Igor Khatkov, Ruben de Kleine, Arto Kokkola, David A. Kooby, Daan Lips, Misha Luyer, Ravi Marudanayagam, Krishna Menon, Quintus Molenaar, Matteo de Pastena, Andrea Pietrabissa, Rushda Rajak, Edoardo Rosso, Patricia Sanchez Velazquez, Olivier Saint Marc, Mihir Shah, Zahir Soonawalla, Ales Tomazic, Caroline Verbeke, Joanne Verheij, Steven White, Hanneke W. Wilmink, Alessandro Zerbi, Marcel G. Dijkgraaf, Marc G. Besselink, Mohammad Abu Hilal, for the European Consortium on Minimally Invasive Pancreatic Surgery (E-MIPS), van Hilst J., Korrel M., Lof S., de Rooij T., Vissers F., Al-Sarireh B., Alseidi A., Bateman A.C., Bjornsson B., Boggi U., Bratlie S.O., Busch O., Butturini G., Casadei R., Dijk F., Dokmak S., Edwin B., van Eijck C., Esposito A., Fabre J.-M., Falconi M., Ferrari G., Fuks D., Groot Koerkamp B., Hackert T., Keck T., Khatkov I., de Kleine R., Kokkola A., Kooby D.A., Lips D., Luyer M., Marudanayagam R., Menon K., Molenaar Q., de Pastena M., Pietrabissa A., Rajak R., Rosso E., Sanchez Velazquez P., Saint Marc O., Shah M., Soonawalla Z., Tomazic A., Verbeke C., Verheij J., White S., Wilmink H.W., Zerbi A., Dijkgraaf M.G., Besselink M.G., Abu Hilal M., CCA - Cancer Treatment and quality of life, Pathology, HUS Abdominal Center, II kirurgian klinikka, Surgery, Graduate School, CCA - Cancer Treatment and Quality of Life, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Anesthesiology, Oncology, Epidemiology and Data Science, and APH - Methodology
- Subjects
ANTEGRADE MODULAR PANCREATOSPLENECTOMY ,Medicine (General) ,Lymphovascular invasion ,SURGERY ,medicine.medical_treatment ,INTERNATIONAL STUDY-GROUP ,Left pancreatectomy ,Distal pancreatectomy ,Medicine (miscellaneous) ,030230 surgery ,law.invention ,Pancreatic ductal adenocarcinoma ,Study Protocol ,0302 clinical medicine ,Postoperative Complications ,Randomized controlled trial ,law ,Retrospective Studie ,IMPLEMENTATION ,Outpatient clinic ,Pharmacology (medical) ,Lymph node ,Randomized Controlled Trials as Topic ,TOTAL LAPAROSCOPIC PANCREATICODUODENECTOMY ,Robot-assisted ,3. Good health ,medicine.anatomical_structure ,Treatment Outcome ,Pancreatic Ductal ,030220 oncology & carcinogenesis ,Human ,Carcinoma, Pancreatic Ductal ,medicine.medical_specialty ,RESECTION ,ENHANCED RECOVERY ,Splenectomy ,Pancreatic surgery ,CLASSIFICATION ,CLINICAL-TRIAL ,03 medical and health sciences ,R5-920 ,Laparoscopic ,Pancreatectomy ,Minimally invasive ,Pancreatic cancer ,Pancreatic tail resection ,Humans ,Quality of Life ,Retrospective Studies ,Laparoscopy ,Pancreatic Neoplasms ,medicine ,business.industry ,Kirurgi ,Carcinoma ,3126 Surgery, anesthesiology, intensive care, radiology ,medicine.disease ,Surgery ,Clinical trial ,DEFINITION ,Histopathology ,Postoperative Complication ,business - Abstract
Background Recently, the first randomized trials comparing minimally invasive distal pancreatectomy (MIDP) with open distal pancreatectomy (ODP) for non-malignant and malignant disease showed a 2-day reduction in time to functional recovery after MIDP. However, for pancreatic ductal adenocarcinoma (PDAC), concerns have been raised regarding the oncologic safety (i.e., radical resection, lymph node retrieval, and survival) of MIDP, as compared to ODP. Therefore, a randomized controlled trial comparing MIDP and ODP in PDAC regarding oncological safety is warranted. We hypothesize that the microscopically radical resection (R0) rate is non-inferior for MIDP, as compared to ODP. Methods/design DIPLOMA is an international randomized controlled, patient- and pathologist-blinded, non-inferiority trial performed in 38 pancreatic centers in Europe and the USA. A total of 258 patients with an indication for elective distal pancreatectomy with splenectomy because of proven or highly suspected PDAC of the pancreatic body or tail will be randomly allocated to MIDP (laparoscopic or robot-assisted) or ODP in a 1:1 ratio. The primary outcome is the microscopically radical resection margin (R0, distance tumor to pancreatic transection and posterior margin ≥ 1 mm), which is assessed using a standardized histopathology assessment protocol. The sample size is calculated with the following assumptions: 5% one-sided significance level (α), 80% power (1-β), expected R0 rate in the open group of 58%, expected R0 resection rate in the minimally invasive group of 67%, and a non-inferiority margin of 7%. Secondary outcomes include time to functional recovery, operative outcomes (e.g., blood loss, operative time, and conversion to open surgery), other histopathology findings (e.g., lymph node retrieval, perineural- and lymphovascular invasion), postoperative outcomes (e.g., clinically relevant complications, hospital stay, and administration of adjuvant treatment), time and site of disease recurrence, survival, quality of life, and costs. Follow-up will be performed at the outpatient clinic after 6, 12, 18, 24, and 36 months postoperatively. Discussion The DIPLOMA trial is designed to investigate the non-inferiority of MIDP versus ODP regarding the microscopically radical resection rate of PDAC in an international setting. Trial registration ISRCTN registry ISRCTN44897265. Prospectively registered on 16 April 2018.
- Published
- 2021
30. A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms
- Author
-
Franz Sellner, Georg Göbel, Daniel Neureiter, Ruben H J de Kleine, Reinhold Függer, Ines Fischer, Elisabeth J. M. Nieveen van Dijkum, Philipp Ellmerer, R. Klug, H. Wundsam, Valentina Andreasi, K. Marsoner, Benno Cardini, Stefan Stättner, Frederik J H Hoogwater, Florian Primavesi, A. Hauer, Charlotte M. Heidsma, Uwe Fröschl, Massimo Falconi, Eckhard Klieser, Tobias Kiesslich, Sabine Thalhammer, Peter Kornprat, Dietmar Öfner, Detlef K. Bartsch, Dominik Wiese, Stefano Partelli, Surgery, AGEM - Digestive immunity, Amsterdam Gastroenterology Endocrinology Metabolism, Primavesi, F., Andreasi, V., Hoogwater, F. J. H., Partelli, S., Wiese, D., Heidsma, C., Cardini, B., Klieser, E., Marsoner, K., Froschl, U., Thalhammer, S., Fischer, I., Gobel, G., Hauer, A., Kiesslich, T., Ellmerer, P., Klug, R., Neureiter, D., Wundsam, H., Sellner, F., Kornprat, P., Fugger, R., Ofner, D., Nieveen van Dijkum, E. J. M., Bartsch, D. K., de Kleine, R. H. J., Falconi, M., and Stattner, S.
- Subjects
Cancer Research ,medicine.medical_specialty ,Survival ,GLASGOW PROGNOSTIC SCORE ,risk score ,SURGICAL COMPLICATIONS ,GUIDELINES ,DIAGNOSIS ,lcsh:RC254-282 ,survival ,Article ,CLASSIFICATION ,C-reactive protein ,surgery ,03 medical and health sciences ,0302 clinical medicine ,PROPOSAL ,Epidemiology ,medicine ,EPIDEMIOLOGY ,pancreas ,Pancreas ,Pancreatic neuroendocrine tumors ,Grading (tumors) ,Framingham Risk Score ,pancreatic neuroendocrine tumors ,biology ,neuroendocrine neoplasms ,business.industry ,Histology ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,SYSTEMIC INFLAMMATORY RESPONSE ,EFFICACY ,CANCER ,Surgery ,medicine.anatomical_structure ,Oncology ,Neuroendocrine neoplasms ,030220 oncology & carcinogenesis ,Cohort ,biology.protein ,Risk score ,030211 gastroenterology & hepatology ,business ,Cohort study - Abstract
Background: Oncological survival after resection of pancreatic neuroendocrine neoplasms (panNEN) is highly variable depending on various factors. Risk stratification with preoperatively available parameters could guide decision-making in multidisciplinary treatment concepts. C-reactive Protein (CRP) is linked to inferior survival in several malignancies. This study assesses CRP within a novel risk score predicting histology and outcome after surgery for sporadic non-functional panNENs. Methods: A retrospective multicenter study with national exploration and international validation. CRP and other factors associated with overall survival (OS) were evaluated by multivariable cox-regression to create a clinical risk score (CRS). Predictive values regarding OS, disease-specific survival (DSS), and recurrence-free survival (RFS) were assessed by time-dependent receiver-operating characteristics. Results: Overall, 364 patients were included. Median CRP was significantly higher in patients >, 60 years, G3, and large tumors. In multivariable analysis, CRP was the strongest preoperative factor for OS in both cohorts. In the combined cohort, CRP (cut-off &ge, 0.2mg/dL, hazard-ratio (HR):3.87), metastases (HR:2.80), and primary tumor size &ge, 3.0cm (HR:1.83) showed a significant association with OS. A CRS incorporating these variables was associated with postoperative histological grading, T category, nodal positivity, and 90-day morbidity/mortality. Time-dependent area-under-the-curve at 60 months for OS, DSS, and RFS was 69%, 77%, and 67%, respectively (all p <, 0.001), and the inclusion of grading further improved the predictive potential (75%, 84%, and 78%, respectively). Conclusions: CRP is a significant marker of unfavorable oncological characteristics in panNENs. The proposed internationally validated CRS predicts histological features and patient survival.
- Published
- 2020
31. Rare primary liver cancers: An EASL position paper.
- Author
-
Wege H, Campani C, de Kleine R, Meyer T, Nault JC, Pawlik TM, Reig M, Ricke J, Sempoux C, Torzilli G, and Zucman-Rossi J
- Abstract
In recent years, owing to advances in our understanding of hepatocarcinogenesis, rare primary liver cancers (PLCs), including combined hepatocellular-cholangiocarcinoma, fibrolamellar carcinoma, and hepatic epithelioid hemangioendothelioma have garnered increased attention. In this position paper, an international panel of experts representing oncology, hepatology, pathology, radiology, surgery, and molecular biology has summarised the available information and evidence on the pathogenesis, diagnosis, and treatment of rare PLCs. While clinical trials of systemic treatments are underway for some rare PLCs, it is evident that more research, involving national and international collaboration, is required., (Copyright © 2024. Published by Elsevier B.V.)
- Published
- 2024
- Full Text
- View/download PDF
32. Materials Challenges in the Electric Vehicle Transition.
- Author
-
He D, Keith DR, Kim HC, De Kleine R, Anderson J, and Doolan M
- Subjects
- Electricity, Automobiles, Recycling
- Abstract
The ongoing transition toward electric vehicles (EVs) is changing materials used for vehicle production, of which the consequences for the environmental performance of EVs are not well understood and managed. We demonstrate that electrification coupled with lightweighting of automobiles will lead to significant changes in the industry's demand not only for battery materials but also for other materials used throughout the entire vehicle. Given the automotive industry's substantial consumption of raw materials, changes in its material demands are expected to trigger volatilities in material prices, consequently impacting the material composition and attractiveness of EVs. In addition, the materials recovered during end-of-life recycling of EVs as the vehicle fleet turns over will impact recycled material supplies both positively and negatively, impacting material availabilities and the economic incentive to engage in recycling. These supply chain impacts will influence material usage and the associated environmental performance of not only the automotive sector but also other metal-heavy industries such as construction. In light of these challenges, we propose the need for new research to understand the dynamic materials impacts of the EV transition that encompasses its implications on EV adoption and fleet life cycle environmental performance. Effectively coordinating the coevolution of material supply chains is crucial for making the sustainable transition to EVs a reality.
- Published
- 2024
- Full Text
- View/download PDF
33. Psychological Interventions for PTSD, Depression, and Anxiety in Child, Adolescent and Adult Forced Migrants: A Systematic Review and Frequentist and Bayesian Meta-Analyses.
- Author
-
Molendijk M, Baart C, Schaffeld J, Akçakaya Z, Rönnau C, Kooistra M, de Kleine R, Strater C, and Mooshammer L
- Subjects
- Humans, Adolescent, Child, Adult, Anxiety Disorders therapy, Anxiety Disorders psychology, Psychosocial Intervention methods, Transients and Migrants psychology, Transients and Migrants statistics & numerical data, Refugees psychology, Depressive Disorder therapy, Depressive Disorder psychology, Stress Disorders, Post-Traumatic therapy, Stress Disorders, Post-Traumatic psychology, Bayes Theorem
- Abstract
Objective: The number of forced migrants has been rising for years. Many forced migrants suffer from post-traumatic stress disorder (PTSD), depression, and/or anxiety and need treatment. Here, we evaluate the effectiveness of psychological interventions (CBT, EMDR, expressive/art, mindfulness, mixed elements, NET and psychoeducation) in reducing symptoms of PTSD, depression, and anxiety in forced migrants., Design and Data Sources: Systematic searches in PubMed and Web of Science and searches of preprint servers and grey literature were performed (final search date: 1 September 2023). Random-effects frequentist and Bayesian meta-analyses were used for data synthesis., Results: We included 84 studies on treatment effects in adults (pooled N = 6302) and 32 on children and adolescents (pooled N = 1097). Our data show a reduction in symptoms of PTSD, depression and anxiety symptoms in both adults and child/adolescent forced migrants. Pooled pre- to post-treatment effects (effect size Cohen's d) ranged from -1.03 to -0.26 for PTSD, from -0.91 to -0.11 for depression and from -0.91 to -0.60 for anxiety, without there being differences in outcome per study design (i.e., RCT comparison vs. non-RCT comparison vs. single arm treatment study). Treatment effects remained evident over follow-up, and not a single type of treatment stood out as being superior to other treatment types. Structural differences in populations (e.g., regarding country of origin) over studies, however, could have hampered the validity of the comparisons between study characteristics such as treatment type., Conclusion: Our findings support the effectiveness of psychological treatment in adult and child/adolescent forced migrants., (© 2024 The Author(s). Clinical Psychology & Psychotherapy published by John Wiley & Sons Ltd.)
- Published
- 2024
- Full Text
- View/download PDF
34. Treatment strategies for hepatic artery complications after pediatric liver transplantation: A systematic review.
- Author
-
Li W, Bokkers RPH, Dierckx RAJO, Verkade HJ, Sanders DH, de Kleine R, and van der Doef HPJ
- Subjects
- Child, Humans, Liver Diseases, Retrospective Studies, Hepatic Artery, Liver Transplantation adverse effects, Thrombosis etiology
- Abstract
This study aimed to evaluate the effectiveness of different treatments for hepatic artery thrombosis (HAT) and hepatic artery stenosis (HAS) after pediatric liver transplantation. We systematically reviewed studies published since 2000 that investigated the management of HAT and/or HAS after pediatric liver transplantation. Studies with a minimum of 5 patients in one of the treatment methods were included. The primary outcomes were technical success rate and graft and patient survival. The secondary outcomes were hepatic artery patency, complications, and incidence of HAT and HAS. Of 3570 studies, we included 19 studies with 328 patients. The incidence was 6.2% for HAT and 4.1% for HAS. Patients with an early HAT treated with surgical revascularization had a median graft survival of 45.7% (interquartile range, 30.7%-60%) and a patient survival of 61.3% (interquartile range, 58.7%-66.9%) compared with the other treatments (conservative, endovascular revascularization, or retransplantation). As for HAS, endovascular and surgical revascularization groups had a patient survival of 85.7% and 100% (interquartile range, 85%-100%), respectively. Despite various treatment methods, HAT after pediatric liver transplantation remains a significant issue that has profound effects on the patient and graft survival. Current evidence is insufficient to determine the most effective treatment for preventing graft failure., (Copyright © 2023 American Association for the Study of Liver Diseases.)
- Published
- 2024
- Full Text
- View/download PDF
35. Practice variation and outcomes of minimally invasive minor liver resections in patients with colorectal liver metastases: a population-based study.
- Author
-
de Graaff MR, Klaase JM, de Kleine R, Elfrink AKE, Swijnenburg RJ, M Zonderhuis B, D Mieog JS, Derksen WJM, Hagendoorn J, van den Boezem PB, Rijken AM, Gobardhan PD, Marsman HA, Liem MSL, Leclercq WKG, van Heek TNT, Pantijn GA, Bosscha K, Belt EJT, Vermaas M, Torrenga H, Manusama ER, van den Tol P, Oosterling SJ, den Dulk M, Grünhagen DJ, and Kok NFM
- Subjects
- Humans, Hepatectomy methods, Length of Stay, Retrospective Studies, Laparoscopy methods, Liver Neoplasms secondary, Colorectal Neoplasms surgery, Colorectal Neoplasms pathology
- Abstract
Introduction: In 2017, the Southampton guideline stated that minimally invasive liver resections (MILR) should considered standard practice for minor liver resections. This study aimed to assess recent implementation rates of minor MILR, factors associated with performing MILR, hospital variation, and outcomes in patients with colorectal liver metastases (CRLM)., Methods: This population-based study included all patients who underwent minor liver resection for CRLM in the Netherlands between 2014 and 2021. Factors associated with MILR and nationwide hospital variation were assessed using multilevel multivariable logistic regression. Propensity-score matching (PSM) was applied to compare outcomes between minor MILR and minor open liver resections. Overall survival (OS) was assessed with Kaplan-Meier analysis on patients operated until 2018., Results: Of 4,488 patients included, 1,695 (37.8%) underwent MILR. PSM resulted in 1,338 patients in each group. Implementation of MILR increased to 51.2% in 2021. Factors associated with not performing MILR included treatment with preoperative chemotherapy (aOR 0.61 CI:0.50-0.75, p < 0.001), treatment in a tertiary referral hospital (aOR 0.57 CI:0.50-0.67, p < 0.001), and larger diameter and number of CRLM. Significant hospital variation was observed in use of MILR (7.5% to 93.0%). After case-mix correction, six hospitals performed fewer, and six hospitals performed more MILRs than expected. In the PSM cohort, MILR was associated with a decrease in blood loss (aOR 0.99 CI:0.99-0.99, p < 0.01), cardiac complications (aOR 0.29, CI:0.10-0.70, p = 0.009), IC admissions (aOR 0.66, CI:0.50-0.89, p = 0.005), and shorter hospital stay (aOR CI:0.94-0.99, p < 0.01). Five-year OS rates for MILR and OLR were 53.7% versus 48.6%, p = 0.21., Conclusion: Although uptake of MILR is increasing in the Netherlands, significant hospital variation remains. MILR benefits short-term outcomes, while overall survival is comparable to open liver surgery., (© 2023. The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
36. Etiology and Outcome of Adult and Pediatric Acute Liver Failure in Europe.
- Author
-
Lenz D, Hørby Jørgensen M, Kelly D, Cardinale V, Geerts A, Gonçalves Costa I, Fichtner A, Garbade SF, Hegen B, Hilberath J, de Kleine R, Kupčinskas L, McLin V, Niesert M, Prado Gonzalez V, Sturm E, Staufner C, Tjwa E, Willemse J, Zecher BF, Larsen FS, Sebode M, and Ytting H
- Subjects
- Humans, Adult, Child, Europe epidemiology, Liver Failure, Acute diagnosis, Liver Failure, Acute epidemiology, Liver Failure, Acute etiology, Liver Transplantation adverse effects, Chemical and Drug Induced Liver Injury
- Abstract
Acute liver failure (ALF) is rare but life-threatening. Common causes include intoxications, infections, and metabolic disorders. Indeterminate etiology is still frequent. No systematic data on incidence, causes, and outcome of ALF across Europe are available. Via an online survey we reached out to European Reference Network Centers on rare liver diseases. Numbers and etiology of ALF cases during 2020 were retrieved and diagnostic and treatment availabilities assessed. In total, 455 cases (306 adult, 149 pediatric) were reported from 36 centers from 20 countries. Intoxication was the most common cause in adult and pediatric care. The number of cases with indeterminate etiology is low. Diagnostic tools and specific treatment options are broadly available within this network. This is the first approach to report on etiology and outcome of ALF in the pediatric and adult population in Europe. High diagnostic yield and standard of care reflects the expert status of involved centers., Competing Interests: The authors report no conflicts of interest., (Copyright © 2023 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.)
- Published
- 2023
- Full Text
- View/download PDF
37. Impaired action-safety learning and excessive relief during avoidance in patients with anxiety disorders.
- Author
-
De Kleine RA, Hutschemaekers MHM, Hendriks GJ, Kampman M, Papalini S, Van Minnen A, and Vervliet B
- Subjects
- Humans, Conditioning, Classical physiology, Avoidance Learning physiology, Affect, Extinction, Psychological physiology, Fear physiology, Obsessive-Compulsive Disorder
- Abstract
Anxiety-related disorders are characterized by high levels of avoidance, but experimental research into avoidance learning in patients is scarce. To fill this gap, we compared healthy controls (HC, n = 47) with patients with obsessive-compulsive disorder (OCD, n = 33), panic disorder with agoraphobia (PDA, n = 40), and post-traumatic stress disorder (PTSD, n = 66) in a computer-based avoidance learning task, in order to examine (1) differences in rates of avoidance responses, (2) differences in action-safety learning during avoidance, and (3) differences in subjective relief following successful avoidance. The task comprised aversive negative pictures (unconditional stimulus, US) that followed pictures of two colored lamps (conditional stimuli, CS+), but not a third colored lamp (safety stimulus, CS-), and could be avoided by pressing a button during one CS+ (CS+ avoidable) but not the other (CS+ unavoidable). Participants rated their US-expectancy and level of relief on a trial-by-trial basis. Compared to the HC group, patient groups displayed higher levels of avoidance to the safety stimulus, and higher levels of US-expectancy and relief following the safety and avoidable danger stimulus. We propose that patients with anxiety disorders have low confidence in the safety consequences of avoidance actions, which induces increased relief during US omissions that reinforce the avoidance action., Competing Interests: Conflict of interest All authors declare to have no conflict of interest related to the presented work., (Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
38. Carbon Footprint of Alternative Grocery Shopping and Transportation Options from Retail Distribution Centers to Customer.
- Author
-
Kemp NJ, Li L, Keoleian GA, Kim HC, Wallington TJ, and De Kleine R
- Subjects
- Carbon Footprint, Greenhouse Effect, Humans, Pandemics, Transportation, COVID-19, Greenhouse Gases
- Abstract
The COVID-19 pandemic has accelerated the growth of e-commerce and automated warehouses, vehicles, and robots and has created new options for grocery supply chains. We report and compare the greenhouse gas (GHG) emissions for a 36-item grocery basket transported along 72 unique paths from a centralized warehouse to the customer, including impacts of micro-fulfillment centers, refrigeration, vehicle automation, and last-mile transportation. Our base case is in-store shopping with last-mile transportation using an internal combustion engine (ICE) SUV (6.0 kg CO
2 e). The results indicate that emissions reductions could be achieved by e-commerce with micro-fulfillment centers (16-54%), customer vehicle electrification (18-42%), or grocery delivery (22-65%) compared to the base case. In-store shopping with an ICE pick-up truck has the highest emissions of all paths investigated (6.9 kg CO2 e) while delivery using a sidewalk automated robot has the least (1.0 kg CO2 e). Shopping frequency is an important factor for households to consider, e.g. halving shopping frequency can reduce GHG emissions by 44%. Trip chaining also offers an opportunity to reduce emissions with approximately 50% savings compared to the base case. Opportunities for grocers and households to reduce grocery supply chain carbon footprints are identified and discussed.- Published
- 2022
- Full Text
- View/download PDF
39. Carbon implications of marginal oils from market-derived demand shocks.
- Author
-
Masnadi MS, Benini G, El-Houjeiri HM, Milivinti A, Anderson JE, Wallington TJ, De Kleine R, Dotti V, Jochem P, and Brandt AR
- Abstract
Expanded use of novel oil extraction technologies has increased the variability of petroleum resources and diversified the carbon footprint of the global oil supply
1 . Past life-cycle assessment (LCA) studies overlooked upstream emission heterogeneity by assuming that a decline in oil demand will displace average crude oil2 . We explore the life-cycle greenhouse gas emissions impacts of marginal crude sources, identifying the upstream carbon intensity (CI) of the producers most sensitive to an oil demand decline (for example, due to a shift to alternative vehicles). We link econometric models of production profitability of 1,933 oilfields (~90% of the 2015 world supply) with their production CI. Then, we examine their response to a decline in demand under three oil market structures. According to our estimates, small demand shocks have different upstream CI implications than large shocks. Irrespective of the market structure, small shocks (-2.5% demand) displace mostly heavy crudes with ~25-54% higher CI than that of the global average. However, this imbalance diminishes as the shocks become bigger and if producers with market power coordinate their response to a demand decline. The carbon emissions benefits of reduction in oil demand are systematically dependent on the magnitude of demand drop and the global oil market structure., (© 2021. The Author(s), under exclusive licence to Springer Nature Limited.)- Published
- 2021
- Full Text
- View/download PDF
40. Minimally invasive versus open distal pancreatectomy for pancreatic ductal adenocarcinoma (DIPLOMA): study protocol for a randomized controlled trial.
- Author
-
van Hilst J, Korrel M, Lof S, de Rooij T, Vissers F, Al-Sarireh B, Alseidi A, Bateman AC, Björnsson B, Boggi U, Bratlie SO, Busch O, Butturini G, Casadei R, Dijk F, Dokmak S, Edwin B, van Eijck C, Esposito A, Fabre JM, Falconi M, Ferrari G, Fuks D, Groot Koerkamp B, Hackert T, Keck T, Khatkov I, de Kleine R, Kokkola A, Kooby DA, Lips D, Luyer M, Marudanayagam R, Menon K, Molenaar Q, de Pastena M, Pietrabissa A, Rajak R, Rosso E, Sanchez Velazquez P, Saint Marc O, Shah M, Soonawalla Z, Tomazic A, Verbeke C, Verheij J, White S, Wilmink HW, Zerbi A, Dijkgraaf MG, Besselink MG, and Abu Hilal M
- Subjects
- Humans, Pancreatectomy adverse effects, Postoperative Complications, Quality of Life, Randomized Controlled Trials as Topic, Retrospective Studies, Treatment Outcome, Carcinoma, Pancreatic Ductal surgery, Laparoscopy, Pancreatic Neoplasms surgery
- Abstract
Background: Recently, the first randomized trials comparing minimally invasive distal pancreatectomy (MIDP) with open distal pancreatectomy (ODP) for non-malignant and malignant disease showed a 2-day reduction in time to functional recovery after MIDP. However, for pancreatic ductal adenocarcinoma (PDAC), concerns have been raised regarding the oncologic safety (i.e., radical resection, lymph node retrieval, and survival) of MIDP, as compared to ODP. Therefore, a randomized controlled trial comparing MIDP and ODP in PDAC regarding oncological safety is warranted. We hypothesize that the microscopically radical resection (R0) rate is non-inferior for MIDP, as compared to ODP., Methods/design: DIPLOMA is an international randomized controlled, patient- and pathologist-blinded, non-inferiority trial performed in 38 pancreatic centers in Europe and the USA. A total of 258 patients with an indication for elective distal pancreatectomy with splenectomy because of proven or highly suspected PDAC of the pancreatic body or tail will be randomly allocated to MIDP (laparoscopic or robot-assisted) or ODP in a 1:1 ratio. The primary outcome is the microscopically radical resection margin (R0, distance tumor to pancreatic transection and posterior margin ≥ 1 mm), which is assessed using a standardized histopathology assessment protocol. The sample size is calculated with the following assumptions: 5% one-sided significance level (α), 80% power (1-β), expected R0 rate in the open group of 58%, expected R0 resection rate in the minimally invasive group of 67%, and a non-inferiority margin of 7%. Secondary outcomes include time to functional recovery, operative outcomes (e.g., blood loss, operative time, and conversion to open surgery), other histopathology findings (e.g., lymph node retrieval, perineural- and lymphovascular invasion), postoperative outcomes (e.g., clinically relevant complications, hospital stay, and administration of adjuvant treatment), time and site of disease recurrence, survival, quality of life, and costs. Follow-up will be performed at the outpatient clinic after 6, 12, 18, 24, and 36 months postoperatively., Discussion: The DIPLOMA trial is designed to investigate the non-inferiority of MIDP versus ODP regarding the microscopically radical resection rate of PDAC in an international setting., Trial Registration: ISRCTN registry ISRCTN44897265 . Prospectively registered on 16 April 2018., (© 2021. The Author(s).)
- Published
- 2021
- Full Text
- View/download PDF
41. Life Cycle Greenhouse Gas Emissions for Last-Mile Parcel Delivery by Automated Vehicles and Robots.
- Author
-
Li L, He X, Keoleian GA, Kim HC, De Kleine R, Wallington TJ, and Kemp NJ
- Abstract
Increased E-commerce and demand for contactless delivery during the COVID-19 pandemic have fueled interest in robotic package delivery. We evaluate life cycle greenhouse gas (GHG) emissions for automated suburban ground delivery systems consisting of a vehicle (last-mile) and a robot (final-50-feet). Small and large cargo vans (125 and 350 cubic feet; V125 and V350) with an internal combustion engine (ICEV) and battery electric (BEV) powertrains were assessed for three delivery scenarios: (i) conventional , human-driven vehicle with human delivery; (ii) partially automated , human-driven vehicle with robot delivery; and (iii) fully automated , connected automated vehicle (CAV) with robot delivery. The robot's contribution to life cycle GHG emissions is small (2-6%). Compared to the conventional scenario, full automation results in similar GHG emissions for the V350-ICEV but 10% higher for the V125-BEV. Conventional delivery with a V125-BEV provides the lowest GHG emissions, 167 g CO
2 e/package, while partially automated delivery with a V350-ICEV generates the most at 486 g CO2 e/package. Fuel economy and delivery density are key parameters, and electrification of the vehicle and carbon intensity of the electricity have a large impact. CAV power requirements and efficiency benefits largely offset each other, and automation has a moderate impact on life cycle GHG emissions.- Published
- 2021
- Full Text
- View/download PDF
42. Long-term morbidity and follow-up after choledochal malformation surgery; A plea for a quality of life study.
- Author
-
de Kleine RH, Ten Hove A, and Hulscher JBF
- Subjects
- Humans, Biliary Tract Surgical Procedures adverse effects, Cholangiocarcinoma etiology, Cholangitis etiology, Choledochal Cyst surgery, Outcome Assessment, Health Care, Quality of Life
- Abstract
Much about the aetiology, pathophysiology, natural course and optimal treatment of choledochal malformation remains under debate. Surgeons continuously strive to optimize their roles in the management of choledochal malformation. Nowadays the standard treatment is complete cyst excision followed by Roux-en-Y hepaticojejunostomy, be it via a laparotomy, laparoscopy or robot-assisted procedure. Whatever surgical endeavor is undertaken, it will be a major operation, with significant morbidity. It is important to realize that especially in asymptomatic cases, this is considered prophylactic surgery, aimed at preventing symptoms but even more important the development of malignancy later in life. A clear overview of long-term outcomes is therefore necessary. This paper aims to review the long-term outcomes after surgery for choledochal malformation. We will focus on biliary complications such as cholangitis, the development of malignancy and quality of life. We will try and identify factors related to a worse outcome. Finally, we make a plea for a large scale study into quality and course of life after resection of a choledochal malformation, to help patients, parents and their treating physicians to come to a well-balanced decision regarding the treatment of a choledochal malformation., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2020
- Full Text
- View/download PDF
43. Longitudinal course of suicidal ideation and predictors of its persistence - A NESDA study.
- Author
-
Kivelä L, Krause-Utz A, Mouthaan J, Schoorl M, de Kleine R, Elzinga B, Eikelenboom M, Penninx BW, van der Does W, and Antypa N
- Subjects
- Adult, Demography, Female, Humans, Incidence, Longitudinal Studies, Male, Netherlands epidemiology, Risk Factors, Disease Progression, Suicidal Ideation
- Abstract
Background: Prior research indicates that the factors that trigger suicidal ideation may differ from those that maintain it, but studies into the maintenance of suicidal ideation remain scarce. Our aim was to assess the longitudinal course of suicidal ideation, and to identify predictors of persistent suicidal ideation., Methods: We used data from the Netherlands Study of Depression and Anxiety (NESDA). We performed a linear mixed-effects growth model analysis (n = 230 with current suicidal ideation at baseline) to assess the course of suicidal ideation over time (baseline through 2-, 4-, 6- and 9-year follow-up). We used logistic regression analysis (n = 195) to test whether factors previously associated with the incidence of suicidal ideation in the literature (insomnia, hopelessness, loneliness, borderline personality traits, childhood trauma, negative life events) also predict persistence of suicidal ideation (i.e., reporting ideation at two consecutive assessment points, 6- and 9-years). We controlled for socio-demographics, clinical diagnosis and severity, medication use, and suicide attempt history., Results: Suicidal ideation decreased over time, and this decrease became slower with increasing time, with the majority of symptom reductions occurring in the first two years of follow-up. More severe insomnia and hopelessness were associated with increased odds of persistent suicidal ideation, and hopelessness was a significant mediator of the relationship between insomnia and persistent suicidal ideation., Limitations: Findings may not generalize to those with more severe suicidal ideation due to dropout of those with the worst clinical profile., Conclusions: Targeting insomnia and hopelessness in treatment may be particularly important to prevent the persistence of suicidal ideation., (Copyright © 2019. Published by Elsevier B.V.)
- Published
- 2019
- Full Text
- View/download PDF
44. A Dynamic Fleet Model of U.S Light-Duty Vehicle Lightweighting and Associated Greenhouse Gas Emissions from 2016 to 2050.
- Author
-
Milovanoff A, Kim HC, De Kleine R, Wallington TJ, Posen ID, and MacLean HL
- Subjects
- Greenhouse Effect, Motor Vehicles, Steel, Vehicle Emissions, Greenhouse Gases
- Abstract
Substituting conventional materials with lightweight materials is an effective way to reduce the life cycle greenhouse gas (GHG) emissions from light-duty vehicles. However, estimated GHG emission reductions of lightweighting depend on multiple factors including the vehicle powertrain technology and efficiency, lightweight material employed, and end-of-life material recovery. We developed a fleet-based life cycle model to estimate the GHG emission changes due to lightweighting the U.S. light-duty fleet from 2016 to 2050, using either high strength steel or aluminum as the lightweight material. Our model estimates that implementation of an aggressive lightweighting scenario using aluminum reduces 2016 through 2050 cumulative life cycle GHG emissions from the fleet by 2.9 Gt CO
2 eq (5.6%), and annual emissions in 2050 by 11%. Lightweighting has the greatest GHG emission reduction potential when implemented in the near-term, with two times more reduction per kilometer traveled if implemented in 2016 rather than in 2030. Delaying implementation by 15 years sacrifices 72% (2.1 Gt CO2 eq) of the cumulative GHG emission mitigation potential through 2050. Lightweighting is an effective solution that could provide important near-term GHG emission reductions especially during the next 10-20 years when the fleet is dominated by conventional powertrain vehicles.- Published
- 2019
- Full Text
- View/download PDF
45. Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD): A Multicenter Patient-blinded Randomized Controlled Trial.
- Author
-
de Rooij T, van Hilst J, van Santvoort H, Boerma D, van den Boezem P, Daams F, van Dam R, Dejong C, van Duyn E, Dijkgraaf M, van Eijck C, Festen S, Gerhards M, Groot Koerkamp B, de Hingh I, Kazemier G, Klaase J, de Kleine R, van Laarhoven C, Luyer M, Patijn G, Steenvoorde P, Suker M, Abu Hilal M, Busch O, and Besselink M
- Subjects
- Female, Follow-Up Studies, Humans, Laparoscopy methods, Male, Middle Aged, Quality of Life, Retrospective Studies, Robotic Surgical Procedures methods, Treatment Outcome, Minimally Invasive Surgical Procedures methods, Pancreatectomy methods, Pancreatic Neoplasms surgery, Recovery of Function
- Abstract
Objective: This trial followed a structured nationwide training program in minimally invasive distal pancreatectomy (MIDP), according to the IDEAL framework for surgical innovation, and aimed to compare time to functional recovery after minimally invasive and open distal pancreatectomy (ODP)., Background: MIDP is increasingly used and may enhance postoperative recovery as compared with ODP, but randomized studies are lacking., Methods: A multicenter patient-blinded randomized controlled superiority trial was performed in 14 centers between April 2015 and March 2017. Adult patients with left-sided pancreatic tumors confined to the pancreas without vascular involvement were randomly assigned (1:1) to undergo MIDP or ODP. Patients were blinded for type of surgery using a large abdominal dressing. The primary endpoint was time to functional recovery. Analysis was by intention to treat. This trial was registered with the Netherlands Trial Register (NTR5689)., Results: Time to functional recovery was 4 days [interquartile range (IQR) 3-6) in 51 patients after MIDP versus 6 days (IQR 5-8) in 57 patients after ODP (P < 0.001). The conversion rate of MIDP was 8%. Operative blood loss was less after MIDP (150 vs 400 mL; P < 0.001), whereas operative time was longer (217 vs 179 minutes; P = 0.005). The Clavien-Dindo grade ≥III complication rate was 25% versus 38% (P = 0.21). Delayed gastric emptying grade B/C was seen less often after MIDP (6% vs 20%; P = 0.04). Postoperative pancreatic fistulas grade B/C were seen in 39% after MIDP versus 23% after ODP (P = 0.07), without difference in percutaneous catheter drainage (22% vs 20%; P = 0.77). Quality of life (day 3-30) was better after MIDP as compared with ODP, and overall costs were non-significantly less after MIDP. No 90-day mortality was seen after MIDP versus 2% (n = 1) after ODP., Conclusions: In patients with left-sided pancreatic tumors confined to the pancreas, MIDP reduces time to functional recovery compared with ODP. Although the overall rate of complications was not reduced, MIDP was associated with less delayed gastric emptying and better quality of life without increasing costs.
- Published
- 2019
- Full Text
- View/download PDF
46. Review of the Fuel Saving, Life Cycle GHG Emission, and Ownership Cost Impacts of Lightweighting Vehicles with Different Powertrains.
- Author
-
Luk JM, Kim HC, De Kleine R, Wallington TJ, and MacLean HL
- Subjects
- Costs and Cost Analysis, Electricity, Gasoline, Ownership, Electric Power Supplies, Motor Vehicles, Vehicle Emissions
- Abstract
The literature analyzing the fuel saving, life cycle greenhouse gas (GHG) emission, and ownership cost impacts of lightweighting vehicles with different powertrains is reviewed. Vehicles with lower powertrain efficiencies have higher fuel consumption. Thus, fuel savings from lightweighting internal combustion engine vehicles can be higher than those of hybrid electric and battery electric vehicles. However, the impact of fuel savings on life cycle costs and GHG emissions depends on fuel prices, fuel carbon intensities and fuel storage requirements. Battery electric vehicle fuel savings enable reduction of battery size without sacrificing driving range. This reduces the battery production cost and mass, the latter results in further fuel savings. The carbon intensity of electricity varies widely and is a major source of uncertainty when evaluating the benefits of fuel savings. Hybrid electric vehicles use gasoline more efficiently than internal combustion engine vehicles and do not require large plug-in batteries. Therefore, the benefits of lightweighting depend on the vehicle powertrain. We discuss the value proposition of the use of lightweight materials and alternative powertrains. Future assessments of the benefits of vehicle lightweighting should capture the unique characteristics of emerging vehicle powertrains.
- Published
- 2017
- Full Text
- View/download PDF
47. [Liver transplantation in paediatric patients in the Netherlands; evolution over the past two decades].
- Author
-
Werner MJM, de Kleine RHJ, Bodewes FAJA, de Boer MT, de Jong KP, de Meijer VE, Scheenstra R, Sieders E, Verkade HJJ, and Porte RJ
- Subjects
- Academic Medical Centers, Child, Child, Preschool, Cohort Studies, Female, Humans, Infant, Male, Netherlands, Postoperative Complications epidemiology, Reoperation statistics & numerical data, Retrospective Studies, Survival Rate, Tissue Donors statistics & numerical data, Treatment Outcome, Liver Transplantation statistics & numerical data
- Abstract
Objective: To evaluate the results of the national paediatric liver transplantation programme in the University Medical Centre (UMC) Groningen in the Netherlands during the past two decades., Design: Retrospective cohort study., Method: We analysed data from paediatric patients who underwent liver transplantation at UMC Groningen in the period 1995-2016. We compared outcomes from children who had undergone a liver transplantation in the period 1995-2005 (cohort A; n = 126) and in the period 2006-2016 (cohort B; n = 169). We performed a subanalysis in cohort B between liver transplantations with deceased donor livers (n = 132) and living donor liver transplantations (LDLT; n = 37)., Results: In cohort A, almost all livers came from deceased donors (99%), whereas in cohort B, 37 LDLTs (22%) were performed. The median age of recipients was significantly higher in cohort A (4.4 vs. 2.5 years; p = 0.015). Postoperative complications were comparable for both cohorts. Re-transplantations within a year after transplantation were more often performed in cohort A than in cohort B (25% vs. 12%; p = 0.004). Following LDLT, there was 2 times (5.4%) an indication for re-transplantation. In cohort B the 5-year survival rate was better than in cohort A (83 vs. 71%; p = 0.014). In cohort B, 5-year survival was higher after LDLT than after transplantation with a deceased donor liver (95 vs. 81%; p = 0.025)., Conclusion: Outcomes after paediatric liver transplantation in the Netherlands have further improved during the past two decades. With an actuarial 5-year survival of 83% in the most recent cohort, and as high as 95% following LDLT, we can say that the UMC Groningen has a successful national paediatric liver transplant programme.
- Published
- 2017
48. Exposing therapists to trauma-focused treatment in psychosis: effects on credibility, expected burden, and harm expectancies.
- Author
-
van den Berg DP, van der Vleugel BM, de Bont PA, Thijssen G, de Roos C, de Kleine R, Kraan T, Ising H, de Jongh A, van Minnen A, and van der Gaag M
- Abstract
Background: Despite robust empirical support for the efficacy of trauma-focused treatments, the dissemination proves difficult, especially in relation to patients with comorbid psychosis. Many therapists endorse negative beliefs about the credibility, burden, and harm of such treatment., Objective: This feasibility study explores the impact of specialized training on therapists' beliefs about trauma-focused treatment within a randomized controlled trial., Method: Therapist-rated (n=16) credibility, expected burden, and harm expectancies of trauma-focused treatment were assessed at baseline, post-theoretical training, post-technical training, post-supervised practical training, and at 2-year follow-up. Credibility and burden beliefs of therapists concerning the treatment of every specific patient in the trial were also assessed., Results: Over time, therapist-rated credibility of trauma-focused treatment showed a significant increase, whereas therapists' expected burden and harm expectancies decreased significantly. In treating posttraumatic stress disorder (PTSD) in patients with psychotic disorders (n=79), pre-treatment symptom severity was not associated with therapist-rated credibility or expected burden of that specific treatment. Treatment outcome had no influence on patient-specific credibility or burden expectancies of therapists., Conclusions: These findings support the notion that specialized training, including practical training with supervision, has long-term positive effects on therapists' credibility, burden, and harm beliefs concerning trauma-focused treatment.
- Published
- 2016
- Full Text
- View/download PDF
49. Feasibility of brief intensive exposure therapy for PTSD patients with childhood sexual abuse: a brief clinical report.
- Author
-
Hendriks L, de Kleine R, van Rees M, Bult C, and van Minnen A
- Abstract
Despite the strong empirical support for the effectiveness of exposure-based treatments in ameliorating post-traumatic stress disorder (PTSD), improvement of treatment is wanted given relatively high dropout rates and challenges of treating patients with high comorbidity and treatment-interfering stressors. The purpose of the current paper is to introduce an intensive exposure treatment program, illustrated by four case descriptions of PTSD patients, who suffered multiple (sexual) traumas in childhood, had high levels of comorbidity and psychosocial stressors, and failed to improve during "regular" trauma-focused treatment programs. The program consisted of psychoeducation, prolonged imaginal exposure, exposure in vivo, exposure by drawings combined with narrative reconstructing, and writing assignments about central trauma-related cognitions. The treatment included 5 working days with individual sessions (in total 30 h of treatment) provided by a team of four therapists. The PTSD symptoms of all patients decreased substantially and the effect sizes were large (Cohen's d resp. 1.5 [pre-post], 2.4 [pre-FU1 month], and 2.3 [pre-FU3 months]). Also, none of the patients showed symptom worsening or dropped out. The evaluation of these four pilot cases suggests that it is possible to intensify exposure treatment, even for multiple traumatized PTSD patients with high comorbidity. We concluded that the first results of this new, intensive exposure program for PTSD patients with childhood sexual abuse are promising.
- Published
- 2010
- Full Text
- View/download PDF
50. Hybrid FMT-CT imaging of amyloid-beta plaques in a murine Alzheimer's disease model.
- Author
-
Hyde D, de Kleine R, MacLaurin SA, Miller E, Brooks DH, Krucker T, and Ntziachristos V
- Subjects
- Animals, Humans, Mice, Subtraction Technique, Alzheimer Disease diagnosis, Brain diagnostic imaging, Brain pathology, Disease Models, Animal, Microscopy, Fluorescence methods, Plaque, Amyloid diagnostic imaging, Plaque, Amyloid pathology, Tomography, X-Ray Computed methods
- Abstract
The need to study molecular and functional parameters of Alzheimer's disease progression in animal models has led to the development of disease-specific fluorescent markers. However, curved optical interfaces and a highly heterogeneous internal structure make quantitative fluorescence imaging of the murine brain a particularly challenging tomographic problem. We investigated the integration of X-ray computed tomography (CT) information into a state-of-the-art fluorescence molecular tomography (FMT) scheme and establish that the dual-modality approach is essential for high fidelity reconstructions of distributed fluorescence within the murine brain, as compared to conventional fluorescence tomography. We employ this method in vivo using a fluorescent oxazine dye to quantify amyloid-beta plaque burden in transgenic APP23 mice modeling Alzheimer's disease. Multi-modal imaging allows for accurate signal localization and correlation of in vivo findings to ex vivo studies. The results point to FMT-CT as an essential tool for in vivo study of neurodegenerative disease in animal models and potentially humans.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.